Source 1primary paper2025MED
Toolkit/CRISPRi/a
CRISPRi/a
Also known as: CRISPRa, CRISPRi
Taxonomy: Mechanism Branch / Architecture. Workflows sit above the mechanism and technique branches rather than replacing them.
Summary
Advanced modalities, including base and prime editing, CRISPRi/a, and RNA-targeting Cas systems, improve precision and reduce genomic damage
Usefulness & Problems
Why this is useful
CRISPRi/a is listed as an advanced CRISPR modality in neurodegenerative disease applications. In the abstract it is grouped with approaches that improve precision and reduce genomic damage.; advanced CRISPR modulation in neurodegeneration
Source:
CRISPRi/a is listed as an advanced CRISPR modality in neurodegenerative disease applications. In the abstract it is grouped with approaches that improve precision and reduce genomic damage.
Source:
advanced CRISPR modulation in neurodegeneration
Problem solved
supports precision-oriented CRISPR intervention
Source:
supports precision-oriented CRISPR intervention
Problem links
supports precision-oriented CRISPR intervention
LiteratureCRISPRi/a is listed as an advanced CRISPR modality in neurodegenerative disease applications. In the abstract it is grouped with approaches that improve precision and reduce genomic damage.
Source:
CRISPRi/a is listed as an advanced CRISPR modality in neurodegenerative disease applications. In the abstract it is grouped with approaches that improve precision and reduce genomic damage.
Taxonomy & Function
Primary hierarchy
Mechanism Branch
Architecture: A composed arrangement of multiple parts that instantiates one or more mechanisms.
Mechanisms
No mechanism tags yet.
Techniques
No technique tags yet.
Target processes
editingImplementation Constraints
cofactor dependency: cofactor requirement unknownencoding mode: genetically encodedimplementation constraint: context specific validationimplementation constraint: multi component delivery burdenoperating role: sensorswitch architecture: multi component
Operational role: sensor. Architecture cues: multi component. Implementation mode: genetically encoded. Cofactor status: cofactor requirement unknown.
Uses more than one coordinated component. Independent follow-up evidence is still limited. Validation breadth across biological contexts is still narrow. Independent reuse still looks limited, so the evidence base may be fragile. Multi-component delivery and stoichiometry control can make deployment harder. No canonical validation observations are stored yet, so context-specific performance remains under-specified.
Validation
Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication
Supporting Sources
Ranked Claims
CRISPR-based diagnostics such as SHERLOCK and DETECTR, together with AI-assisted sgRNA design and machine-learning off-target prediction, enhance the safety, stratification, and monitoring of CRISPR therapeutics.
Base editing, prime editing, CRISPRi/a, and RNA-targeting Cas systems improve precision and reduce genomic damage, which is particularly advantageous in post-mitotic neurons.
Approval Evidence
1 source1 linked approval claimfirst-pass slug crispri-a
Advanced modalities, including base and prime editing, CRISPRi/a, and RNA-targeting Cas systems, improve precision and reduce genomic damage
Source:
performance advantagesupports
Base editing, prime editing, CRISPRi/a, and RNA-targeting Cas systems improve precision and reduce genomic damage, which is particularly advantageous in post-mitotic neurons.
Source:
Comparisons
Source-backed strengths
included among modalities that improve precision and reduce genomic damage
Source:
included among modalities that improve precision and reduce genomic damage
Compared with Cry/Vip pyramiding
CRISPRi/a and Cry/Vip pyramiding address a similar problem space because they share editing.
Shared frame: same top-level item type; shared target processes: editing
Compared with prime-editing
CRISPRi/a and prime-editing address a similar problem space because they share editing.
Shared frame: same top-level item type; shared target processes: editing
Strengths here: looks easier to implement in practice; may avoid an exogenous cofactor requirement.
Relative tradeoffs: appears more independently replicated.
CRISPRi/a and rs1800378-targeted allele-selective CRISPR/Cas9 VWF disruption strategy address a similar problem space because they share editing.
Shared frame: same top-level item type; shared target processes: editing
Ranked Citations
- 1.